Nanalyze
Quality: In-depth research on disruptive technology stocks
Clarity: Future-proof language everyone can easily understand
Objectivity: Taking the emotion out of investing with a straightforward approach
Humor: Giving you your daily recommended dose of sarcasm in every article
Newest Articles
When Will Exact Sciences Release a Multi-Cancer Test?
Remember Theranos and its founder, Elizabeth Holmes, who is now serving an 11-year-plus sentence in federal prison for fraud? It turns out that detecting dozens of different diseases with a single drop of blood is a pretty difficult trick, especially while you’re busy screwing your investors and your chief operating officer. Someone should make a […]
Remember Theranos and its founder, Elizabeth Holmes, who is now serving an 11-year-plus sentence in...
About Nanalyze
We’re a team of MBAs with decades of experience who decided to work 80 hours a week for ourselves rather than 40 hours a week for someone else. Part researchers, part investment managers, part journalists, we deliver a straightforward, rules-based approach to investing that benefits new and seasoned investors alike. We specialize in two main investing strategies: disruptive technology (Nanalyze) and dividend growth (Quantigence). With real-money portfolios under management, we understand the importance of a risk-averse approach to investing. Through real-world examples, we teach people how to become better investors.
We are experts in the below fields
Videos
Sign up to our newsletter to get more of our great research delivered straight to your inbox!
Nanalyze Weekly includes useful insights written by our team of underpaid MBAs, research on new disruptive technology stocks flying under the radar, and summaries of our recent research. Always 100% free.
